Skip to content
← Back to explorer

SHIELD: Semantic Heterogeneity Integrated Embedding for Latent Discovery in Clinical Trial Safety Signals

Francois Vandenhende, Anna Georgiou, Theodoros Psaras, Ellie Karekla · Feb 23, 2026 · Citations: 0

Data freshness

Extraction: Fresh

Check recency before relying on this page for active eval decisions. Use stale pages as context and verify against current hub results.

Metadata refreshed

Feb 23, 2026, 1:55 PM

Stale

Extraction refreshed

Apr 13, 2026, 6:41 AM

Fresh

Extraction source

Persisted extraction

Confidence 0.15

Abstract

We present SHIELD, a novel methodology for automated and integrated safety signal detection in clinical trials. SHIELD combines disproportionality analysis with semantic clustering of adverse event (AE) terms applied to MedDRA term embeddings. For each AE, the pipeline computes an information-theoretic disproportionality measure (Information Component) with effect size derived via empirical Bayesian shrinkage. A utility matrix is constructed by weighting semantic term-term similarities by signal magnitude, followed by spectral embedding and clustering to identify groups of related AEs. Resulting clusters are annotated with syndrome-level summary labels using large language models, yielding a coherent, data-driven representation of treatment-associated safety profiles in the form of a network graph and hierarchical tree. We implement the SHIELD framework in the context of a single-arm incidence summary, to compare two treatment arms or for the detection of any treatment effect in a multi-arm trial. We illustrate its ability to recover known safety signals and generate interpretable, cluster-based summaries in a real clinical trial example. This work bridges statistical signal detection with modern natural language processing to enhance safety assessment and causal interpretation in clinical trials.

Low-signal caution for protocol decisions

Use this page for context, then validate protocol choices against stronger HFEPX references before implementation decisions.

  • Extraction flags indicate low-signal or possible false-positive protocol mapping.
  • Extraction confidence is 0.15 (below strong-reference threshold).
  • No explicit evaluation mode was extracted from available metadata.
  • No benchmark/dataset or metric anchors were extracted.

HFEPX Relevance Assessment

This paper is adjacent to HFEPX scope and is best used for background context, not as a primary protocol reference.

Best use

Background context only

Use if you need

Background context only.

Main weakness

Extraction flags indicate low-signal or possible false-positive protocol mapping.

Trust level

Low

Eval-Fit Score

0/100 • Low

Treat as adjacent context, not a core eval-method reference.

Human Feedback Signal

Not explicit in abstract metadata

Evaluation Signal

Weak / implicit signal

HFEPX Fit

Adjacent candidate

Extraction confidence: Low

Field Provenance & Confidence

Each key protocol field shows extraction state, confidence band, and data source so you can decide whether to trust it directly or validate from full text.

Human Feedback Types

missing

None explicit

Confidence: Low Source: Persisted extraction missing

No explicit feedback protocol extracted.

Evidence snippet: We present SHIELD, a novel methodology for automated and integrated safety signal detection in clinical trials.

Evaluation Modes

missing

None explicit

Confidence: Low Source: Persisted extraction missing

Validate eval design from full paper text.

Evidence snippet: We present SHIELD, a novel methodology for automated and integrated safety signal detection in clinical trials.

Quality Controls

missing

Not reported

Confidence: Low Source: Persisted extraction missing

No explicit QC controls found.

Evidence snippet: We present SHIELD, a novel methodology for automated and integrated safety signal detection in clinical trials.

Benchmarks / Datasets

missing

Not extracted

Confidence: Low Source: Persisted extraction missing

No benchmark anchors detected.

Evidence snippet: We present SHIELD, a novel methodology for automated and integrated safety signal detection in clinical trials.

Reported Metrics

missing

Not extracted

Confidence: Low Source: Persisted extraction missing

No metric anchors detected.

Evidence snippet: We present SHIELD, a novel methodology for automated and integrated safety signal detection in clinical trials.

Rater Population

missing

Unknown

Confidence: Low Source: Persisted extraction missing

Rater source not explicitly reported.

Evidence snippet: We present SHIELD, a novel methodology for automated and integrated safety signal detection in clinical trials.

Human Data Lens

  • Uses human feedback: No
  • Feedback types: None
  • Rater population: Unknown
  • Unit of annotation: Unknown
  • Expertise required: Medicine
  • Extraction source: Persisted extraction

Evaluation Lens

  • Evaluation modes:
  • Agentic eval: None
  • Quality controls: Not reported
  • Confidence: 0.15
  • Flags: low_signal, possible_false_positive

Protocol And Measurement Signals

Benchmarks / Datasets

No benchmark or dataset names were extracted from the available abstract.

Reported Metrics

No metric terms were extracted from the available abstract.

Research Brief

Deterministic synthesis

We present SHIELD, a novel methodology for automated and integrated safety signal detection in clinical trials. HFEPX protocol signal is limited in abstract-level metadata, so treat it as adjacent context. Updated from current HFEPX corpus.

Generated Apr 13, 2026, 6:41 AM · Grounded in abstract + metadata only

Key Takeaways

  • We present SHIELD, a novel methodology for automated and integrated safety signal detection in clinical trials.
  • Resulting clusters are annotated with syndrome-level summary labels using large language models, yielding a coherent, data-driven representation of treatment-associated safety…

Researcher Actions

  • Treat this as method context, then pivot to protocol-specific HFEPX hubs.
  • Identify benchmark choices from full text before operationalizing conclusions.
  • Verify metric definitions before comparing against your eval pipeline.

Caveats

  • Generated from title, abstract, and extracted metadata only; full-paper implementation details are not parsed.
  • Low-signal flag detected: protocol relevance may be indirect.

Research Summary

Contribution Summary

  • We present SHIELD, a novel methodology for automated and integrated safety signal detection in clinical trials.
  • Resulting clusters are annotated with syndrome-level summary labels using large language models, yielding a coherent, data-driven representation of treatment-associated safety profiles in the form of a network graph and hierarchical tree.
  • We illustrate its ability to recover known safety signals and generate interpretable, cluster-based summaries in a real clinical trial example.

Why It Matters For Eval

  • We present SHIELD, a novel methodology for automated and integrated safety signal detection in clinical trials.
  • Resulting clusters are annotated with syndrome-level summary labels using large language models, yielding a coherent, data-driven representation of treatment-associated safety profiles in the form of a network graph and hierarchical tree.

Researcher Checklist

  • Gap: Human feedback protocol is explicit

    No explicit human feedback protocol detected.

  • Gap: Evaluation mode is explicit

    No clear evaluation mode extracted.

  • Gap: Quality control reporting appears

    No calibration/adjudication/IAA control explicitly detected.

  • Gap: Benchmark or dataset anchors are present

    No benchmark/dataset anchor extracted from abstract.

  • Gap: Metric reporting is present

    No metric terms extracted.

Related Papers

Papers are ranked by protocol overlap, extraction signal alignment, and semantic proximity.

No related papers found for this item yet.

Need human evaluators for your AI research? Scale annotation with expert AI Trainers.